Australian Court Upholds Pfizer's Lipitor Patent
An Australian court has dismissed Ranbaxy Pharmaceuticals Inc.'s appeal of an order that prevented the drugmaker from launching a generic version of Pfizer Inc.'s anti-cholesterol drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article